Breast implants are artificial surgery prosthesis made of either silicone gel, silica or saline solutions, which involves reconstruction of breasts to improve the effects of mastectomy or other damages to breasts. This breast implantation procedure is also called as breast augmentation. Breast implant and its reconstruction requires tissue expanders that helps in the expansion of breast muscles and skin. A permanent breast implant is inserted post removal of the tissue expander. Breast implant procedure is performed mostly in an outpatient basis, which takes only an hour or two to finish the implantation process. However, the surgery time can be extended depending on the patient’s condition of breasts, the type of implant to be used, and other factors.
Click To Continue Reading on Asian Breast Implants Market
The Asian Breast Implants market size is estimated to be valued at US$ 140.93 Mn in 2017 and is expected to witness a robust CAGR of 7.0% during the forecast period (2018 – 2026).
There are few complications and adverse outcomes of breast implants, which could hamper growth of breast implants market. This includes additional surgeries with or without removal of the device, capsular contracture, occurrence of scar tissue around the implant and squeezes the implant, breast pain, changes in nipple and breast sensation, rupture with deflation of saline-filled implants, rupture with or without symptoms (silent rupture) of silicone gel-filled implants.
Key Vendors:
Allergen, Inc., Mentor Worldwide LLC, GC Aesthetics Plc, Johnson & Johnson, POLYTECH Health and Aesthetics GmBH, Groupe Sebbin SAS, Arion Laboratories, HansBiomed Co.Ltd. and GG Biotechnology Ltd.